<prompt> Which of the following anticancer drugs are competitive inhibitors of tyrosine kinase ?Imatinib and suntinibLetrozoleBicalutamideFulvestrant  <response>: Ans. is a i.e., Imatinib and suntinib Molecular targeted agents Tyrosine kinase inhibitors Competitive inhibitors - Imatinib, Nilotinib, Sunitinib, Dasatinib, Erlotinib, Gefitinib, Lapitinib, Sorafinib Remember all ends with nib. Monoclonal antibodies - Cetuximab, panitumomab. HER2neu ERB B2 inhibitors Monoclonal antibody - Transtuzumab. Targeted antibody - Gemtuzomab anti CD-33, Rituximab anti - CD20, Alemtuzumab anti CD-52. Vascular endothelial growth factor VEGF inhibitor - Monoclonal antibody - Bevacizumab. Proteosome inhibitors - Boezomib. Histone deacylase inhibitor - Vorinostat DNA - methyl transferase inhibitor - 5-azacytidine, 2-deoxy-5 azacytidine. All - trans - retinoic acid. Biological response modifier - Recombinant IL-2 aldesleukin, denileukin. 